NDC 59627-002-07 - AVONEX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59627-002
- Requested NDC
- 59627-002-07
- Package NDCs from labels
- 59627-002-07, 59627-002-06
- Manufacturer
- Biogen Inc. | Packaging Coordinators, LLC
- Effective date
- 2025-11-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AVONEX - Biogen Inc. | Packaging Coordinators, LLC | Biogen Inc. | Packaging Coordinators, LLC | 2025-11-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59627-002-06 | Avonex | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 23 | |
| 59627-002-07 | Avonex | 1 in 1 TRAY | INJECTION, SOLUTION | 1 | 23 | |
| 59627-002-07 | Avonex | 0.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.5 | 23 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59627-002 | AVONEX (INTERFERON BETA-1A) KIT AVONEX PEN (INTERFERON BETA-1A) INJECTION, SOLUTION AVONEX (INTERFERON BETA-1A) INJECTION, SOLUTION [BIOGEN INC.] | 22 | Current NDC, Legacy NDC, 3 package rows | 20241115_d70a39cc-de15-4c12-a1ec-8063b69ea0e1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59627-002-05 | EA - Each | 59627-002 | 31696ccb-f2fd-4e79-9d20-4172258cd419 | 1 | 2012-07-24 |
| 59627-002-06 | ML - Milliliter | 59627-002 | a90c5f27-cfdb-465e-8b90-9c2a34c90f3e | 1 | 2021-09-07 |
| 59627-002-07 | ML - Milliliter | 59627-002 | 5e7add05-1932-4c66-9876-ff82ad4af6a8 | 2 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| interferon beta-1a | ACTIVE INGREDIENT | XRO4566Q4R | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| ISOPROPYL ALCOHOL | ACTIVE INGREDIENT | ND2M416302 | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| interferon beta-1a | ACTIVE MOIETY | XRO4566Q4R | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| ISOPROPYL ALCOHOL | ACTIVE MOIETY | ND2M416302 | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| acetic acid | INACTIVE INGREDIENT | Q40Q9N063P | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| Arginine hydrochloride | INACTIVE INGREDIENT | F7LTH1E20Y | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| Sodium acetate | INACTIVE INGREDIENT | 4550K0SC9B | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lights Alcohol Wipes | ISOPROPYL ALCOHOL | Lights Medical Manufacture Co., Ltd. | f9601021-4c52-4b48-96c1-b25fe8fef8b1 | 2026-06-26 | Warnings | 797544 ND2M416302 |
| Equate Swimmers Instant Ear Dry | EQUATE SWIMMERS INSTANT EAR DRY | Walmart Stores, Inc | 76b58a7a-48cf-866c-e053-2a91aa0a7e63 | 2026-06-26 | Warnings | ND2M416302 |
| Lights Medium Alcohol | ISOPROPYL ALCOHOL | Lights Medical Manufacture Co., Ltd. | 873e0c9d-e0aa-44bb-a1f4-447458479023 | 2026-06-25 | Warnings | 797544 ND2M416302 |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | Q40Q9N063P |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| Swab Applicator Brushes Iodine (0.7% Available Iodine) and Isopropyl Alcohol (74% w/w) | IODINE, ISOPROPYL ALCOHOL | XINXIANG XINDA TECHNOLOGY CO.,LTD | 54e83df5-bbeb-d068-e063-6394a90ad513 | 2026-06-23 | Warnings | ND2M416302 |
| 70% | ISOPROPYL ALCOHOL | ADUSA Distribution, LLC | f340dd7e-6412-4621-a818-2592ca78d0f2 | 2026-06-23 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ADUSA Distribution, LLC | d95a9736-345b-4b7e-9b24-23edb3cbf7e8 | 2026-06-23 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | ADUSA Distribution, LLC | 7e066163-6629-43ad-b0b8-09c16fe94a0d | 2026-06-23 | Warnings, Adverse reactions | ND2M416302 |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Isopropyl Rubbing Alcohol 70 | ISOPROPYL ALCOHOL | Delon Laboratories (1990) Ltd. | fb481568-0c51-421f-9b73-adb4c84645aa | 2026-06-22 | Warnings | ND2M416302 |
| Medline | ISOPROPYL ALCOHOL | Medline Industries, LP | 495076e9-3187-6bfa-e063-6394a90a01f5 | 2026-06-22 | Warnings | 797544 ND2M416302 |
| ABRILADA | ADALIMUMAB-AFZB | A-S Medication Solutions | 79943fe6-1249-4074-9aed-c53937820d0f | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | 797544 |
| Isopropyl alcohol 91 percent | ISOPROPYL ALCOHOL | P & L Development, LLC | fcda76cb-63c4-4e81-9e0a-13be506a8150 | 2026-06-17 | Warnings | ND2M416302 |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| Zolgensma | ONASEMNOGENE ABEPARVOVEC-XIOI | Novartis Innovative Technologies Inc. | 68cd4f06-70e1-40d8-bedb-609ec0afa471 | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | 797544 |
| Skyrizi | RISANKIZUMAB-RZAA | AbbVie Inc. | 7148c8eb-b39e-e20a-6494-a6df82392858 | 2026-06-15 | Warnings, Adverse reactions | 797544 |
| 70% | ISOPROPYL ALCOHOL | Meijer, Inc. | 7b1f93ff-5eeb-4da1-8f02-7c47d713689a | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | 531cea18-9609-4d78-876d-3ba5d2d1e16f | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Meijer, Inc. | b0d302c2-58a0-4c3e-9c4a-fd34de40c034 | 2026-06-15 | Warnings, Adverse reactions | ND2M416302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.